FinlandiaAdjudicadaPublicado 08 sept 2026
Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027
Productos farmacéuticos· traducción automática de TED
- Comprador
- Pohjois-Pohjanmaan hyvinvointialue(3221326-2)
- Dónde
- POHDE, FI1D9 · Finlandia
- Importe
- 142 €
- Fin del contrato (estimada)
- 01 ene 2028
- Firma o adjudicación
- 11 nov 2025
- Duración
- 24 meses
- Adjudicatarias
- medac Gesellschaft für klinische Spezialpräparate G.m.b.H, sivuliike Suomessa(3157653-9)
- Ailon Pharma Oy(2821736-7)
- Abacus Medicine A/S(DK31501296)
- ALK-Abéllo Nordic A/S(DK28111576)
- AOP Orphan Pharmaceuticals Sweden AB(5591698708)
- AbbVie Oy(2470310-6)
- Abboxia AB(556924-9187)
- Abcur AB(556701-3957)
- Abena Finland OY(2688859-7)
- Accord Healthcare Oy(2425744-1)
- Aguettant Nordic ApS(DK40873309)
- Alexion Pharma Nordics AB(SE556839102201)
- Aspen Pharma Ireland Limited(1090790-9)
- Astellas Pharma a/s(IE3243827QH)
- AstraZeneca Oy(10888638)
- Avansor Pharma Oy(0196941-1)
- Avia Pharma Oy(1835834-2)
- B. Braun Medical Oy(2077990-4)
- Bausch & Lomb Nordic AB(0111467-5)
- Baxter Oy(SE556214818801)
- Bayer Oy(0584473-9)
- Amgen Aktiebolag, filial i Finland(1703777-4)
- Berlin-Chemie/A. Menarini Suomi Oy(2002154-6)
- Berner Oy(0107011-5)
- betapharm Arzneimittel GmbH(DE155988224)
- 2care4 Aps, filial(3206997-7)
- BioGaia Finland Oy(0580158-7)
- Biocodex Oy(SE556757211901)
- Bioglan AB(1597637-2)
- Boehringer Ingelheim Finland Ky(SE556681849701)
- Bracco Imaging Scandinavia AB(1538877-3)
- Biogen Finland Oy(GB70722355)
- CNX Therapeutics Ltd(SE556530197401)
- CSL Behring AB(SE556534028701)
- CampusPharma AB(SE5566679105)
- Camurus AB(2996306-2)
- Celltrion Healthcare Finland Oy(5568275746)
- Chiesi Pharma AB(0600017-5)
- Danone Oy(3297839-6)
- Desitin Pharma Oy(SE556713342501)
- EQL Pharma AB(2039330-7)
- Eisai AB(MT25307813)
- Essential Pharma Limited(2800514-5)
- Evolan Pharma AB(2745346-4)
- Exeltis Sverige AB, filial i Finland(1438172-1)
- Fresenius Medical Care Suomi Oy(0625269-8)
- Ferring Lääkkeet Oy(1509526-8)
- Fresenius Kabi Ab, Sivuliike Suomessa(SE556814170801)
- FrostPharma AB(0927611-8)
- Fysioline Oy(3249850-1)
- G.L. Pharma Nordic AB(SE559279165001)
- GHN Pharma Nordic AB(SE556562092801)
- Galderma Nordic AB(SE5565677449)
- Galenica AB(2514528-1)
- Gedeon Richter Nordics AB(2151739-1)
- Gilead Sciences Finland Oy(0108378-4)
- GlaxoSmithKline Oy(SE559065708501)
- Glenmark Pharmaceuticals Nordic AB(SE556604907701)
- Grifols Nordic AB(3332605-8)
- Grindeks Kalceks Suomi Oy(2189482-4)
- Grünenthal Finland Oy(2657375-5)
- Haleon Finland Oy(DE811165146)
- hameln pharma gmbh(SE559334238801)
- Horus Pharma Nordic(36405449)
- IBSA Nordic(SE556835632201)
- Immedica Pharma Ab(NO931481177MVA)
- Gentili Pharma AS(SE556701310601)
- Institut Produits Synthése (IPSEN) AB(0922140-8)
- Janssen-Cilag Oy(DK39791447)
- Jazz Pharmceuticals Denmark ApS(2644984-2)
- KRKA Finland Oy(SE556309336901)
- Karo Healthcare AB(2391997-6)
- KEBOMED Oy(1799926-0)
- KiiltoClean Oy(0882020-6)
- Kir-Fix Oy(DK38820338)
- Kurantis Aps(556662-3038)
- Kyowa Kirin AB(0807589-1)
- LEO Pharma Oy(HRB 12778)
- MIP Pharma GmbH(0101072-9)
- MSD Finland Oy(DK35234748)
- Macure Pharma ApS(1918478-6)
- Magnum Medical Finland Oy(2078491-4)
- Medans Oy(SE556681710101)
- Medical Valley Invest AB(2285192-2)
- Mediq Suomi Oy(1514187-7)
- Medtronic Finland Oy(0200696-7)
- Merck Oy(1048595-3)
- Mundipharma Oy(1624103-6)
- Navamedic AB(SE559275926901)
- neuraxpharm Sweden AB(1572025-4)
- Nordic Drugs AB, sivuliike Suomessa(DK36893419)
- Nordic Prime ApS(2515178-8)
- NordicInfu Care AB - Filial Finland(DK29310025)
- Norgine Danmark A/S(0100873-3)
- Novartis Finland Oy(2277798-8)
- Novo Nordisk Farma Oy(1558201-5)
- Octapharma Nordic AB, sivuliike Suomessa(2965253-9)
- OneMed Oy(3125262-2)
- Öresund Pharma Aps(1842903-2)
- Organon Finland Oy(1479981-0)
- Orifarm Healthcare Oy(1999212-6)
- Orifarm Oy(SE556615813401)
- Orion Oyj(0107119-3)
- Otsuka Pharma Scandinavia AB(0211069-2)
- Oy Bristol-Myers Squibb (Finland) Ab(1629074-3)
- Oy Eli Lilly Finland Ab(0111018-0)
- Oy GE Healthcare Bio-Sciences Ab(1024811-4)
- Oy H. Lundbeck Ab(2944805-2)
- Oy Swedish Orphan Biovitrum Ab(NO918719679)
- Oy Verman Ab(1026496-6)
- POA Pharma Scandinavia Ab, filial Finland(1763649-4)
- Panpharma Nordic AS(0194053-9)
- Paranova OY(32287824)
- Perrigo Suomi Oy(IT04920860964)
- Pfizer Oy(1896168-6)
- Pharmanovia A/S(556620-8350)
- Pierrel S.p.A.(0498521-4)
- Prothya Biololutions Finland Oy(2630593-7)
- Recordati AB(BE0538813719)
- Roche Oy(2663298-9)
- SAM Nordic Oy(1089311-3)
- Serb SA(DK-27744532)
- STADA Nordic ApS, Suomen sivuliike(1048723-8)
- Sabora Pharma Oy(SE556845899501)
- Sandoz A/S(1703523-4)
- Sanofi Oy(2048215-8)
- Scandinavian Biopharma Distribution(1924100-7)
- SERVIER FINLAND OY(FI29597453)
- Stella Nordic Oy(0111976-7)
- Stragen Finland Oy(NL856933211B01)
- Sun Pharmaceuticals GmbH(1703775-8)
- Suomen Nestlé Oy(0658348-9)
- TD Pharma B.V.(SE 556762-708701)
- Takeda Oy(LT40744584)
- Teva Finland Oy(0114461-2)
- Tillotts Pharma Ab(SE-556557-9967)
- UAB Norameda(3377790-8)
- UCB Pharma Oy Finland(2642738-7)
- Unimedic Pharma AB(556739-3508)
- Vantive Oy(2131015-5)
- Viatris Oy(0113649-5)
- Vifor Pharma Nordiska AB(2495247-9)
- Ofertas recibidas
- 161
- Procedimiento
- open
- Acuerdo marco
- No
- CPV
- 33600000
- Procedimiento (id)
- aa94d8c6-6ca5-428e-bd38-130e66476ed5
- Fuentes
- TED + Hilma